156 related articles for article (PubMed ID: 9367869)
1. Expression of Wnt5a is downregulated by extracellular matrix and mutated c-Ha-ras in the human mammary epithelial cell line MCF-10A.
Bui TD; Tortora G; Ciardiello F; Harris AL
Biochem Biophys Res Commun; 1997 Oct; 239(3):911-7. PubMed ID: 9367869
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
[TBL] [Abstract][Full Text] [Related]
3. Regulation of Wnt5a mRNA expression in human mammary epithelial cells by cell shape, confluence, and hepatocyte growth factor.
Huguet EL; Smith K; Bicknell R; Harris AL
J Biol Chem; 1995 May; 270(21):12851-6. PubMed ID: 7759542
[TBL] [Abstract][Full Text] [Related]
4. Regulation of heparin-binding EGF-like growth factor expression in Ha-ras transformed human mammary epithelial cells.
Martínez-Lacaci I; De Santis M; Kannan S; Bianco C; Kim N; Wallace-Jones B; Wechselberger C; Ebert AD; Salomon DS
J Cell Physiol; 2001 Feb; 186(2):233-42. PubMed ID: 11169460
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of RI alpha subunit of cAMP-dependent protein kinase induces growth inhibition of human mammary epithelial cells transformed by c-Ha-ras and c-erbB-2 proto-oncogenes.
Ciardiello F; Pepe S; Bianco C; Baldassarre G; Ruggiero A; Bianco C; Selvam MP; Bianco AR; Tortora G
Int J Cancer; 1993 Feb; 53(3):438-43. PubMed ID: 8094073
[TBL] [Abstract][Full Text] [Related]
6. Additive effects of c-erbB-2, c-Ha-ras, and transforming growth factor-alpha genes on in vitro transformation of human mammary epithelial cells.
Ciardiello F; Gottardis M; Basolo F; Pepe S; Normanno N; Dickson RB; Bianco AR; Salomon DS
Mol Carcinog; 1992; 6(1):43-52. PubMed ID: 1354442
[TBL] [Abstract][Full Text] [Related]
7. Frequent up-regulation of WNT5A mRNA in primary gastric cancer.
Saitoh T; Mine T; Katoh M
Int J Mol Med; 2002 May; 9(5):515-9. PubMed ID: 11956659
[TBL] [Abstract][Full Text] [Related]
8. Collagen-induced morphogenesis and expression of the alpha 2-integrin subunit is inhibited in c-erbB2-transfected human mammary epithelial cells.
D'Souza B; Berdichevsky F; Kyprianou N; Taylor-Papadimitriou J
Oncogene; 1993 Jul; 8(7):1797-806. PubMed ID: 8099725
[TBL] [Abstract][Full Text] [Related]
9. Mutated c-Ha-ras oncogene alters cytokeratin expression in the human breast epithelial cell line MCF-10A.
Paine TM; Fontanini G; Basolo F; Geronimo I; Elliott JW; Russo J
Am J Pathol; 1992 Jun; 140(6):1483-8. PubMed ID: 1376561
[TBL] [Abstract][Full Text] [Related]
10. Sustained Wnt protein expression in chondral constructs from mesenchymal stem cells.
Nishioka K; Dennis JE; Gao J; Goldberg VM; Caplan AI
J Cell Physiol; 2005 Apr; 203(1):6-14. PubMed ID: 15389636
[TBL] [Abstract][Full Text] [Related]
11. WNT5A expression in human breast cancer.
Leris AC; Roberts TR; Jiang WG; Newbold RF; Mokbel K
Anticancer Res; 2005; 25(2A):731-4. PubMed ID: 15868903
[TBL] [Abstract][Full Text] [Related]
12. Wnt5a cloning, expression, and up-regulation in human primary breast cancers.
Lejeune S; Huguet EL; Hamby A; Poulsom R; Harris AL
Clin Cancer Res; 1995 Feb; 1(2):215-22. PubMed ID: 9815976
[TBL] [Abstract][Full Text] [Related]
13. Expression and hormone regulation of Wnt2, 3, 4, 5a, 7a, 7b and 10b in normal human endometrium and endometrial carcinoma.
Bui TD; Zhang L; Rees MC; Bicknell R; Harris AL
Br J Cancer; 1997; 75(8):1131-6. PubMed ID: 9099960
[TBL] [Abstract][Full Text] [Related]
14. Regulation of Wnt5a expression in human mammary cells by protein kinase C activity and the cytoskeleton.
Jönsson M; Smith K; Harris AL
Br J Cancer; 1998 Aug; 78(4):430-8. PubMed ID: 9716023
[TBL] [Abstract][Full Text] [Related]
15. Amphiregulin as an autocrine growth factor for c-Ha-ras- and c-erbB-2-transformed human mammary epithelial cells.
Normanno N; Selvam MP; Qi CF; Saeki T; Johnson G; Kim N; Ciardiello F; Shoyab M; Plowman G; Brandt R
Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2790-4. PubMed ID: 7908443
[TBL] [Abstract][Full Text] [Related]
16. Expression and regulation of WNT5A and WNT5B in human cancer: up-regulation of WNT5A by TNFalpha in MKN45 cells and up-regulation of WNT5B by beta-estradiol in MCF-7 cells.
Saitoh T; Katoh M
Int J Mol Med; 2002 Sep; 10(3):345-9. PubMed ID: 12165812
[TBL] [Abstract][Full Text] [Related]
17. Repression of Wnt-5a impairs DDR1 phosphorylation and modifies adhesion and migration of mammary cells.
Jönsson M; Andersson T
J Cell Sci; 2001 Jun; 114(Pt 11):2043-53. PubMed ID: 11493640
[TBL] [Abstract][Full Text] [Related]
18. High expression of Wnt7b in human superficial bladder cancer vs invasive bladder cancer.
Bui TD; O'Brien T; Crew J; Cranston D; Harris AL
Br J Cancer; 1998; 77(2):319-24. PubMed ID: 9461004
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling of a clonal isolate of oxaliplatin-resistant ovarian carcinoma cell line A2780/C10.
Varma RR; Hector SM; Clark K; Greco WR; Hawthorn L; Pendyala L
Oncol Rep; 2005 Oct; 14(4):925-32. PubMed ID: 16142353
[TBL] [Abstract][Full Text] [Related]
20. Caveolin-1 down-regulation is required for Wnt5a-Frizzled 2 signalling in Ha-Ras
Lin HK; Lin HH; Chiou YW; Wu CL; Chiu WT; Tang MJ
J Cell Mol Med; 2018 May; 22(5):2631-2643. PubMed ID: 29502342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
